CN112695097A - 一种区分cyp2d7p和cyp2d8p的cyp2d6*10遗传多态性检测试剂盒 - Google Patents
一种区分cyp2d7p和cyp2d8p的cyp2d6*10遗传多态性检测试剂盒 Download PDFInfo
- Publication number
- CN112695097A CN112695097A CN202011348211.6A CN202011348211A CN112695097A CN 112695097 A CN112695097 A CN 112695097A CN 202011348211 A CN202011348211 A CN 202011348211A CN 112695097 A CN112695097 A CN 112695097A
- Authority
- CN
- China
- Prior art keywords
- cyp2d6
- cyp2d8p
- cyp2d7p
- genetic polymorphism
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010001237 Cytochrome P-450 CYP2D6 Proteins 0.000 title claims abstract description 35
- 102100021704 Cytochrome P450 2D6 Human genes 0.000 title claims abstract description 34
- 102100021702 Putative cytochrome P450 2D7 Human genes 0.000 title claims abstract description 15
- 206010071602 Genetic polymorphism Diseases 0.000 title claims abstract description 12
- 108010066783 cytochrome P-450 CYP2D7P Proteins 0.000 title claims abstract description 11
- 238000001514 detection method Methods 0.000 title abstract description 20
- 239000000523 sample Substances 0.000 claims abstract description 43
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 108091008109 Pseudogenes Proteins 0.000 claims description 11
- 102000057361 Pseudogenes Human genes 0.000 claims description 11
- 102200026593 rs1065852 Human genes 0.000 claims description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- 101000896576 Homo sapiens Putative cytochrome P450 2D7 Proteins 0.000 claims description 4
- 235000019993 champagne Nutrition 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 4
- 239000013642 negative control Substances 0.000 claims description 4
- 101000896586 Homo sapiens Cytochrome P450 2D6 Proteins 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000013641 positive control Substances 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 2
- 239000012498 ultrapure water Substances 0.000 claims description 2
- 230000003321 amplification Effects 0.000 abstract description 27
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 27
- 239000003814 drug Substances 0.000 abstract description 15
- 238000003205 genotyping method Methods 0.000 abstract description 5
- 238000000034 method Methods 0.000 description 15
- 108091006146 Channels Proteins 0.000 description 13
- 229940079593 drug Drugs 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 12
- 230000000694 effects Effects 0.000 description 8
- 239000012634 fragment Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 230000000171 quenching effect Effects 0.000 description 6
- 108700028369 Alleles Proteins 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 125000006853 reporter group Chemical group 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 101100329196 Homo sapiens CYP2D6 gene Proteins 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 101150010738 CYP2D6 gene Proteins 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 102000003691 T-Type Calcium Channels Human genes 0.000 description 1
- 108090000030 T-Type Calcium Channels Proteins 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000003166 hypermetabolic effect Effects 0.000 description 1
- 230000002806 hypometabolic effect Effects 0.000 description 1
- -1 i.e. Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011348211.6A CN112695097B (zh) | 2021-03-10 | 2021-03-10 | 一种区分cyp2d7p和cyp2d8p的cyp2d6*10遗传多态性检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011348211.6A CN112695097B (zh) | 2021-03-10 | 2021-03-10 | 一种区分cyp2d7p和cyp2d8p的cyp2d6*10遗传多态性检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112695097A true CN112695097A (zh) | 2021-04-23 |
CN112695097B CN112695097B (zh) | 2022-08-19 |
Family
ID=75507072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011348211.6A Active CN112695097B (zh) | 2021-03-10 | 2021-03-10 | 一种区分cyp2d7p和cyp2d8p的cyp2d6*10遗传多态性检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112695097B (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151763A (zh) * | 1994-05-06 | 1997-06-11 | 大制药株式会社 | 检测人细胞色素p4502d6基因多态的方法 |
CN102304572A (zh) * | 2006-09-11 | 2012-01-04 | Inje大学校产学协力团 | 用于确定CYP2D6基因的基因型的htSNP及其用于多重基因分型的方法 |
KR20140048482A (ko) * | 2012-10-15 | 2014-04-24 | 대한민국 (식품의약품안전처장) | Cyp2d6 유전자의 유전형을 이용한 트라마돌의 약물반응 예측방법 |
CN105603064A (zh) * | 2015-12-30 | 2016-05-25 | 广州金域检测科技股份有限公司 | 一种检测cyp2d6_g3183a基因多态性的引物及其方法 |
CN106244708A (zh) * | 2016-08-30 | 2016-12-21 | 长沙三济生物科技有限公司 | 定性检测cyp2d6基因分型的焦磷酸测序引物对及试剂盒 |
CN109182474A (zh) * | 2018-09-10 | 2019-01-11 | 江门市妇幼保健院 | 一种cyp2d6基因突变检测引物及试剂盒 |
CN110904220A (zh) * | 2019-12-24 | 2020-03-24 | 圣湘生物科技股份有限公司 | 检测cyp2d6基因多态性和拷贝数的组合物、试剂盒及方法 |
CN112442525A (zh) * | 2020-11-20 | 2021-03-05 | 江苏伟禾生物科技有限公司 | 用于检测人类自然杀伤细胞免疫球蛋白样受体kir基因分型的试剂盒 |
-
2021
- 2021-03-10 CN CN202011348211.6A patent/CN112695097B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151763A (zh) * | 1994-05-06 | 1997-06-11 | 大制药株式会社 | 检测人细胞色素p4502d6基因多态的方法 |
CN102304572A (zh) * | 2006-09-11 | 2012-01-04 | Inje大学校产学协力团 | 用于确定CYP2D6基因的基因型的htSNP及其用于多重基因分型的方法 |
KR20140048482A (ko) * | 2012-10-15 | 2014-04-24 | 대한민국 (식품의약품안전처장) | Cyp2d6 유전자의 유전형을 이용한 트라마돌의 약물반응 예측방법 |
CN105603064A (zh) * | 2015-12-30 | 2016-05-25 | 广州金域检测科技股份有限公司 | 一种检测cyp2d6_g3183a基因多态性的引物及其方法 |
CN106244708A (zh) * | 2016-08-30 | 2016-12-21 | 长沙三济生物科技有限公司 | 定性检测cyp2d6基因分型的焦磷酸测序引物对及试剂盒 |
CN109182474A (zh) * | 2018-09-10 | 2019-01-11 | 江门市妇幼保健院 | 一种cyp2d6基因突变检测引物及试剂盒 |
CN110904220A (zh) * | 2019-12-24 | 2020-03-24 | 圣湘生物科技股份有限公司 | 检测cyp2d6基因多态性和拷贝数的组合物、试剂盒及方法 |
CN112442525A (zh) * | 2020-11-20 | 2021-03-05 | 江苏伟禾生物科技有限公司 | 用于检测人类自然杀伤细胞免疫球蛋白样受体kir基因分型的试剂盒 |
Non-Patent Citations (2)
Title |
---|
NAOKO NAKAMURA等: "Simple and accurate determination of CYP2D6 gene copy number by a loop-mediated isothermal amplification method and an electrochemical DNA chip", 《CLINICA CHIMICA ACTA》 * |
WALTER H. KOCH: "TECHNOLOGY PLATFORMS FOR PHARMACOGENOMIC DIAGNOSTIC ASSAYS", 《NATURE REVIEWS DRUG DISCOVERY》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112695097B (zh) | 2022-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU744746B2 (en) | High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers | |
CN101838683B (zh) | 一种kras基因和/或braf基因的核苷酸突变位点的检测方法 | |
CN107119107A (zh) | 一种检测人类cyp2c19基因多态性的方法及试剂盒 | |
KR20140010093A (ko) | 혼합 집단 중 표적 dna의 서열분석을 위한 키트 및 방법 | |
CN107227361A (zh) | 用于检测cyp2c19基因多态性的引物、探针及检测试剂盒 | |
JP2013081450A (ja) | 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット | |
CN108456721B (zh) | 同步检测基因突变和甲基化的方法及其应用 | |
CN111996244B (zh) | 一种单核苷酸多态性检测用组合物及其应用 | |
CN107338287B (zh) | Taqman-MGB探针检测绵羊BMPR-IB基因A746G突变的试剂盒和方法 | |
CN108949967B (zh) | 用液相芯片技术检测心血管疾病药物基因多态性的特异性引物及试剂盒 | |
CN112695097B (zh) | 一种区分cyp2d7p和cyp2d8p的cyp2d6*10遗传多态性检测试剂盒 | |
CN114085926B (zh) | Abcb1基因c3435t的snp位点多态性的引物和探针、试剂盒及检测方法 | |
JP5757909B2 (ja) | 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット | |
CN111909990B (zh) | 单管同时检测基因的缺失突变和点突变的荧光pcr检测方法 | |
CN112899361A (zh) | 一种基于锁核酸修饰的rma法检测cyp2c9和vkorc1基因多态性的试剂盒 | |
CN107400722B (zh) | 一种检测人基因组的竞争性实时荧光pcr snp探针 | |
US20080096213A1 (en) | Method for confirming conversion treatment and nucleic acid molecule used therefor | |
CN112301120A (zh) | 一种用于检测adrb1基因多态性的探针、引物及试剂盒 | |
CN110804663A (zh) | 检测人cyp2c19基因突变的引物、试剂盒及检测方法 | |
CN114480594B (zh) | 一种检测多个单核苷酸多态性的方法、试剂盒及其应用 | |
CN113265460B (zh) | 检测耳聋基因slc26a4点突变的引物及其应用 | |
JP5635496B2 (ja) | Egfr遺伝子多型検出用プローブおよびその用途 | |
CN107841541A (zh) | Idh1/2基因突变检测体系及其试剂盒 | |
JP2005245272A (ja) | アルコール脱水素酵素遺伝子多型の簡易検出方法および検出用試薬 | |
CN111575370A (zh) | 检测SLC28A3基因rs7853758位点多态性的人工模拟核酸分子信标与试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240528 Address after: Unit 01-2, 03, 7th Floor, Building B13, Xiamen Biomedical Industry Park, 2074 Wengjiao West Road, Haicang District, Xiamen City, Fujian Province, 361000 Patentee after: XIAMEN TONGPU BIOLOGICAL TECHNOLOGY CO.,LTD. Country or region after: China Address before: Siming District of Xiamen city in Fujian Province, 361000 South Siming Road No. 422 Patentee before: XIAMEN University Country or region before: China |